Activation of the tumour suppressor PTEN as an alternative explanation for Trastuzumab's mechanism of action

Authors :: Max S. Mano
A. Di Leo
Ahmad Awada
V. Durbecq
Martine Piccart
A. Minisini
Source :: The Breast. 14:176
Publication Year :: 2005
Publisher :: Elsevier BV, 2005.

Subjects :: biology
business.industry
General Medicine
law.invention
Mechanism of action
Trastuzumab
law
medicine
biology.protein
Cancer research
PTEN
Suppressor
Surgery
medicine.symptom
business
medicine.drug

Tools